Covered recipient · General Payments record
DENA BARKER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$882.80
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $347.87 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $155.08 | 8 |
| Novo Nordisk AS | $41.56 | 2 |
| Averitas Pharma Inc. | $33.59 | 1 |
| PFIZER INC. | $26.28 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.92 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.26 | 1 |
| Amgen Inc. | $18.77 | 1 |
| Insulet Corporation | $17.29 | 1 |
| DEXCOM, INC. | $15.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.75 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483648 | CMS |
| ABBVIE INC. | $31.22 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483650 | CMS |
| ABBVIE INC. | $5.60 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483652 | CMS |
| ABBVIE INC. | $13.78 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483654 | CMS |
| ABBVIE INC. | $25.25 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483656 | CMS |
| ABBVIE INC. | $34.92 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483658 | CMS |
| ABBVIE INC. | $21.98 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483660 | CMS |
| ABBVIE INC. | $14.58 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483662 | CMS |
| Amgen Inc. | $18.77 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117501618 | CMS |
| Averitas Pharma Inc. | $33.59 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133453034 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.26 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086322846 | CMS |
| Dexcom, Inc. | $15.12 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153357691 | CMS |
| Insulet Corporation | $17.29 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116823110 | CMS |
| Novo Nordisk Inc | $16.18 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100601115 | CMS |
| Novo Nordisk Inc | $25.38 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100412969 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.92 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119021780 | CMS |
| PFIZER INC. | $26.28 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131645957 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.